Abstract
Ischemic stroke is a leading cause of death and disability. However, very few neuroprotective agents have shown promise for treatment of ischemic stroke in clinical trials, despite showing efficacy in many successful preclinical studies. This may be attributed, at least in part, to the incongruency between experimental animal stroke models used in preclinical studies and the manifestation of ischemic stroke in humans. Most often the human population selected for clinical trials are more diverse than the experimental model used in a preclinical study. For successful translation, it is critical to develop clinical trial designs that match the experimental animal model used in the preclinical study. This review aims to provide a comprehensive summary of commonly used animal models with clear correlates between rodent models used to study ischemic stroke and the clinical stroke pathologies with which they most closely align. By improving the correlation between preclinical studies and clinical trials, new neuroprotective agents and stroke therapies may be more accurately and efficiently identified.
Similar content being viewed by others
Data Availability
N/A — review article.
References
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11–21.
Berkhemer OA, Fransen PSS, Beumer D, Van Den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.
Hacke W, Kaste M, Fieschl C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA J Am Med Assoc. 1995;274:1017–25.
The National Institute of Neurological Disorder and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. NEJM. 1995;333:1581–7.
Fraser JF. Standardisation of research strategies in acute ischaemic stroke. Lancet Neurol [Internet] Ltd. 2016;15:784–5. https://doi.org/10.1016/S1474-4422(16)30080-1.
Sommer CJ. Ischemic stroke: experimental models and reality. Acta Neuropathol Berlin Heidelberg. 2017;133:245–61.
Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2005;2:396–409.
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–89.
Sohrabji F, Park MJ, Mahnke A. Sex differences in stroke therapies. J Neurosci Res. 2017;95:681–91.
Zhang H, Lin S, Chen X, Gu L, Zhu X, Zhang Y, et al. The effect of age, sex and strains on the performance and outcome in animal models of stroke. Neurochem Int. 2019;127:2–11. https://doi.org/10.1016/j.neuint.2018.10.005 ([Internet]. Elsevier).
Messmer SJ, Fraser JF, Pennypacker KR, Roberts JM. Method of intra-arterial drug administration in a rat: sex based optimization of infusion rate. J Neurosci Methods [Internet]. Elsevier B.V.; 2021;357:109178. Available from:https://doi.org/10.1016/j.jneumeth.2021.109178
Lakomkin N, Dhamoon M, Carroll K, Singh IP, Tuhrim S, Lee J, et al. Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: a 10-year systematic review of the literature. J Neurointerv Surg. 2019;11:241–5.
Rennert RC, Wali AR, Steinberg JA, Santiago-Dieppa DR, Olson SE, Pannell JS, et al. Epidemiology, natural history, and clinical presentation of large vessel ischemic stroke. Neurosurgery. 2019;85:S4-8.
Dabus G, Linfante I. 2012 The natural history of acute ischemic stroke due to intracranial large-vessel occlusion: what do we know? Tech Vasc Interv Radiol [Internet]. Elsevier Inc.;;15:2–4. Available from: https://doi.org/10.1053/j.tvir.2011.12.003
Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–22.
Brouns R, Deyn De, pp. The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg. 2009;111:483–95.
Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Japanese J Stroke. 1986;8:83–94.
Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84–91.
McBride DW, Zhang JH. Precision stroke animal models: the permanent MCAO model should be the primary model, not transient MCAO. Transl Stroke Res. 2017;8:397–404.
Gubskiy IL, Namestnikova DD, Cherkashova EA, Chekhonin VP, Baklaushev VP, Gubsky LV, et al. MRI guiding of the middle cerebral artery occlusion in rats aimed to improve stroke modeling. Transl Stroke Res Translational Stroke Research. 2018;9:417–25.
Olsen TSØJ, Skriver EB, Herning M. Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion. Stroke. 1985;16:459–66.
Li F, Omae T, Fisher M. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats. Stroke. 1999;30:2464–71.
Doerfler A, Forsting M, Reith W, Staff C, Heiland S, Schäbitz WR, et al. Decompressive craniectomy in a rat model of “malignant” cerebral hemispheric stroke: experimental support for an aggressive therapeutic approach. J Neurosurg. 1996;85:853–9.
Messmer SJ, Salmeron KE, Frank JA, McLouth CJ, Lukins DE, Hammond TC, et al. Extended middle cerebral artery occlusion (MCAO) model to mirror stroke patients undergoing thrombectomy. Transl Stroke Res [Internet]. Springer US; 2021; Available from: https://doi.org/10.1007/s12975-021-00936-y
Kassem-Moussa H, Graffagnino C. Nonocclusion and spontaneous recanalization rates in acute ischemic stroke. Arch Neurol. 2002;59:1870.
Zanette EM, Roberti C, Mancini G, Pozzilli C, Bragoni M, Toni D. Spontaneous middle cerebral artery reperfusion in ischemic stroke: A follow-up study with transcranial Doppler. Stroke. 1995;26:430–3.
Jadhav AP, Aghaebrahim A, Jankowitz BT, Haussen DC, Budzik RF, Bonafe A, et al. Benefit of endovascular thrombectomy by mode of onset: secondary analysis of the DAWN trial. Stroke. 2019;50:3141–6.
Kudo M, Aoyama A, Ichimori S, Fukunaga N. An animal model of cerebral infarction. Homologous blood clot emboli in rats. Stroke. 1982;13:505–8.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack; A guideline from the American Heart Association/American Stroke Association. Stroke. 2021.
Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, et al. Mouse model of in situ thromboembolic stroke and reperfusion. Stroke. 2007;38:2771–8.
Hossmann KA. Cerebral ischemia: models, methods and outcomes. Neuropharmacology. 2008;55:257–70.
García-Yébenes I, Sobrado M, Zarruk JG, Castellanos M, De La Ossa NP, Dávalos A, et al. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke. Stroke. 2011;42:196–203.
Won S, Lee JH, Wali B, Stein DG, Sayeed I. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab [Internet]. Nature Publishing Group; 2014;34:72–80. Available from: https://doi.org/10.1038/jcbfm.2013.163
Robinson R, Shoemaker W, Schlumpf M, Valk T, Bloom F. Effect of experimental cerebral infarction in rat brain on catecholamines and behavior. Nature. 1975;255:332–4.
Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:53–60.
Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab. 1988;8:474–85.
Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;17:738–43.
Fluri F, Schuhmann MK, Kleinschnitz C. Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther. 2015;9:3445–54.
Uesugi M, Kasuya Y, Hayashi K, Goto K. SB209670, a potent endothelin receptor antagonist, prevents or delays axonal degeneration after spinal cord injury. Brain Res. 1998;786:235–9.
Watson B, Dietrich W, Busto R, Wachtel M, Ginsberg M. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol. 1985;17:497–504.
Uzdensky AB. Photothrombotic stroke as a model of ischemic stroke. Transl Stroke Res Translational Stroke Research. 2018;9:437–51.
Lu H, Li Y, Yuan L, Li H, Lu X, Tong S. Induction and imaging of photothrombotic stroke in conscious and freely moving rats. J Biomed Opt. 2014;19:1.
Yu CL, Zhou H, Chai AP, Yang YX, Mao RR, Xu L. Whole-scale neurobehavioral assessments of photothrombotic ischemia in freely moving mice. J Neurosci Methods. 2015;239:100–7. https://doi.org/10.1016/j.jneumeth.2014.10.004 ([Internet]. Elsevier B.V).
Liu NW, Ke CC, Zhao Y, Chen YA, Chan KC, Tan DTW, et al. Evolutional characterization of photochemically induced stroke in rats: a multimodality imaging and molecular biological study. Transl Stroke Res Translational Stroke Research. 2017;8:244–56.
Sun YY, Kuo YM, Chen HR, Short-Miller JC, Smucker MR, Kuan CY. A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment. Blood Adv. 2020;4:1222–31.
Karatas H, Erdener SE, Gursoy-Ozdemir Y, Gurer G, Soylemezoglu F, Dunn AK, et al. Thrombotic distal middle cerebral artery occlusion produced by topical FeCl3 application: a novel model suitable for intravital microscopy and thrombolysis studies. J Cereb Blood Flow Metab [Internet]. Nature Publishing Group; 2011;31:1452–60. Available from: https://doi.org/10.1038/jcbfm.2011.8.
Syeara N, Alamri FF, Jayaraman S, Lee P, Karamyan ST, Arumugam TV, et al. Motor deficit in the mouse ferric chloride-induced distal middle cerebral artery occlusion model of stroke. Behav Brain Res. 2020;380:112418. https://doi.org/10.1016/j.bbr.2019.112418 ([Internet]. Elsevier).
Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods. 2003;122:201–11.
Mayzel-Oreg O, Omae T, Kazemi M, Li F, Fisher M, Cohen Y, et al. Microsphere-induced embolic stroke: an MRI study. Magn Reson Med. 2004;51:1232–8.
Walberer M, Rueger MA. The macrosphere model—an embolic stroke model for studying the pathophysiology of focal cerebral ischemia in a translational approach. Ann Transl Med. 2015;3.
Jin Y, Shi P, Wang Y, Li J, Zhang J, Zhao X, et al. Precise control of embolic stroke with magnetized red blood cells in mice. Commun Biol. 2022;5:1–12.
Jia JM, Peng C, Wang Y, Zheng J, Ge WP. Control of occlusion of middle cerebral artery in perinatal and neonatal mice with magnetic force. Mol Brain Molecular Brain. 2018;11:1–10.
Sozmen EG, Hinman JD, Carmichael ST. Models that matter: white matter stroke models. Neurotherapeutics. 2012;9:349–58.
Nunez S, Doroudchi MM, Gleichman AJ, Ng KL, Llorente IL, Sozmen EG, et al. A versatile murine model of subcortical white matter stroke for the study of axonal degeneration and white matter neurobiology. J Vis Exp. 2016;2016:1–7.
Willmot M, Gray L, Gibson C, Murphy S, Bath PMW. A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide - Biol Chem. 2005;12:141–9.
Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1963;27:282–93.
Bailey EL, Smith C, Sudlow CLM, Wardlaw JM. Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review Int J Stroke. 2011;6:434–44.
Bailey EL, Mcculloch J, Sudlow C, Wardlaw JM. Potential animal models of lacunar stroke: a systematic review. Stroke. 2009;40.
Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab. 2008;28:1877–91.
Henninger N, Eberius KH, Sicard KM, Kollmar R, Sommer C, Schwab S, et al. A new model of thromboembolic stroke in the posterior circulation of the rat. J Neurosci Methods. 2006;156:1–9.
Luo M, Tang X, Zhu J, Qiu Z, Jiang Y. Establishment of acute pontine infarction in rats by electrical stimulation. J Vis Exp. 2020
Oliveira-Ferreira AI, Major S, Przesdzing I, Kang EJ, Dreier JP. Spreading depolarizations in the rat endothelin-1 model of focal cerebellar ischemia. J Cereb Blood Flow Metab. 2020;40:1274–89.
Asai Y, Umemura K, Kohno Y, Uematsu T, Nakashima M. An animal model for hearing disturbance due to inner ear ischemia: photochemically induced thrombotic occlusion of the rat anterior inferior cerebellar artery. Eur Arch Otorhinolaryngol. 1993;250:292–6.
Ito A, Fujimura M, Niizuma K, Kanoke A, Sakata H, Morita-Fujimura Y, et al. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease. Brain Res. 2015;1594:310–20. https://doi.org/10.1016/j.brainres.2014.11.014 ([Internet]. Elsevier).
Roberts JM, Maniskas ME, Fraser JF, Bix GJ. Internal carotid artery stenosis: a novel surgical model for moyamoya syndrome. PLoS ONE. 2018;13:1–10.
Sonobe S, Fujimura M, Niizuma K, Fujimura T, Furudate S, Nishijima Y, et al. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene. NeuroReport. 2014;25:1442–6.
Hattori Y, Kitamura A, Nagatsuka K, Ihara M. A novel mouse model of ischemic carotid artery disease. PLoS ONE. 2014;9:1–7.
Hill MD, Goyal M, Menon BK, Nogueira RG, McTaggart RA, Al E. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395:878–87.
Grupke S, Hall J, Dobbs M, Bix GJ, Fraser JF. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview. Clin Neurol Neurosurg. 2015;129:1–9. https://doi.org/10.1016/j.clineuro.2014.11.013 ([Internet]. Elsevier B.V.).
Acknowledgements
We would like to acknowledge the University of Kentucky Medical Center Library for their help and support.
Author information
Authors and Affiliations
Contributions
E. C. J., V. K., S. P., J. L., J. F. F., and K. P. conceptualized the manuscript. A. V. M. drafted the manuscript and conducted the literature search. K. P. and J. F. F. obtained the figures used. All authors critically revised and reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate.
N/A — review article.
Human and Animal Rights.
All animal experiments depicted in the figures of this article were undertaken in accordance with institutional review board approval and with institutional animal care and use committee approval and oversight. Any images of human patients have been completely de-identified to respect their privacy and in accordance with the Health Insurance Portability and Accountability Act. If this manuscript were to be published, the included patients cannot be identified based on the figures.
Consent for Publication.
On behalf of all authors, we consent to the publication of this manuscript.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Matur, A.V., Candelario-Jalil, E., Paul, S. et al. Translating Animal Models of Ischemic Stroke to the Human Condition. Transl. Stroke Res. 14, 842–853 (2023). https://doi.org/10.1007/s12975-022-01082-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-022-01082-9